Impact of dupilumab prescribing on utilization of medical and surgical therapies for chronic rhinosinusitis with nasal polyps.
Christopher M LowAllan R WangMichael YongJayakar V NayakZara M PatelPeter H HwangPublished in: International forum of allergy & rhinology (2024)
Increased dupilumab utilization coincided with decreased ESS in patients with CRSwNP between 2019 and 2021. One potential confounder was the concurrent COVID-19 pandemic, which may have negatively impacted surgery utilization rates.